Higher GARS1 mRNA levels correspond to significantly worse survival in five different cancer types (BLCA, KIRC, LGG, LIHC, and LUAD) compared to only one for KARS1 (HNSC) (Figure 4). This evidence concerns the gene GARS1 and cancer.